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RX Base 3 mos 1yr Base 3 mos 1yr Base 3 mas 1yr
AT 12 +9* +9 17 +7# +15 27.1 +0.6 -0.1
CP 23 -8* -4 33 -7 -4 281 0 +0.2
CL 16 +3 0 22 +5 +2 28.4 +0.3 -0.4
DT 18 +5 +8 29 +6 +16@ 300 -0.9 -0.5
HZ 26 -5 -9 41 -8# -9@ 29.4 -0.5 -1.5
PZ 23 +1 -4 33 -1 +3 28.4 -0.1 +07
PL 16 +5 25 +7 28.3 +0.4 +1.1
* AT v CP 3 mos, # HZ v AT 3 mos, @ HZ v DZ 1 yr (p < 0.05)
Thus, HZ caused a decrease in LVH prevalence, while AT and DT caused an
increase. These changes are concordant with echo observations, where HZ
was the only drug to significantly reduce LV mass for equal levels of systolic
BP reduction.
Unstable angina
Lesion length::: 10 mm
Angulation >45"
Independent Predictors
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Incidence of and Factors Associated with Abrupt
Closure in Patients Undergoing Elective, New Device
Angioplasty in Native Coronary Arteries
Mun K. Hong, Jeffrey J. Popma, S. Chiu Wong, Kenneth M. Kent, Augusto
D. Pichard, Lowell F. Satler, Ya Chien Chuang, Theresa A. Bucher, S. Shareghi,
Martin B. Leon. Washington Hospital Center. Washington, D.C.
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Complications of Coronary Intervention:
Prediction and Management
Monday, March 20, 1995,4:00 p.m.-5:30 p.m.
Ernest N. Morial Convention Center, Room 90
The sole independent predictor for out-of-Iab only abrupt closure was dis-
section (Odds Ratio = 3.11, p < 0.005). We conclude that; (1) The incidence
of abrupt closure (both in- and out-of-Iab) was 3.9% in patients undergoing
elective new device angioplasty, with nearly equal distribution of in- and out-
of-lab occurrences: (2) Unstable angina. lesion length ~ 10 mm, and angula-
tion ~45° predicted either in- or out-of-Iab abrupt closure, whereas dissection
was the sole significant predictor of out-of-Iab only abrupt closure: and (3)
both lesion-related (thrombus-containing lesions for extraction atherectomy)
and device-related factors (stents with subacute thrombosis) added to the
acceptable rates of abrupt closure with these new devices for lesions unfa-
vorable for conventional angioplasty.
c.1. = confidence interval
To determine the incidence and predictors of abrupt closure (TIMI flow = 0
or 1) in patients undergoing new device angioplasty (NDA). we studied the
hospital records and qualitative morphologic and quantitative angiographic
methods of 1,983 patients with unfavorable lesion morphologies treated
electively in native coronary arteries with intracoronary stents (N = 96), ex-
traction atherectomy (TEC; N = 27). directional atherectomy (N = 563), ro-
tational atherectomy (N = 775), or laser (N = 522). The overall incidence
of abrupt closure was 3.9% (78/1983), with 2.1 % (42/78) occurring during
the procedure and 1.8% (36/78) occurring out-of-Iab (1 patient with both in-
and out-of-Iab abrupt closure). Among NDA. TEC (14.8%) and stents (8.3%)
had relatively higher frequencies of abrupt closure compared to other NDAs
(mean of 3.5%). Multivariate analysis of demographic and lesion characteris-
tics revealed the following predictors associated with either in-lab or out-of-
lab abrupt closure:
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1720-21 Predictors of Acute Complications After
Percutaneous Coronary Revascularization with New
Devices
Peter A. McCullough, William W. O'Neill, Melissa May, Anne Lichtenberg,
Michelle Strzelecki, Cindy L. Grines, Robert D. Safian. William Beaumont Hospital,
Royal Oak, MI
Studies of conventional balloon angioplasty (PTCA) have identified female
gender, age, unstable angina. prior coronary bypass surgery. diabetes, le-
sion thrombus, and dissection as predictors of acute complications, but pre-
dictors of the risks of new device interventions are unknown. New devices
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Chronic Hydralazine or Enalapril Normalize
Myosin Isoforms in the Spontaneously
Hypertensive Rat, but Only Enalapril Normalizes
Left Ventricular Mass
Garrie J. Haas, Margaret Ginn Pease, Melinda Hunnicutt, Mary E. Allon, A.
John Merola, Robert J. Cody. The Ohio State University. Columbus, Ohio
These data show that reduction in hemodynamic load induced a change in
myosin isoforms to adult pattern whereas only Q reduced LVMI, suggesting
that LVH reversal may not be dependent solely on hemodynamic load.
Increased V3 myosin isoform is seen in left ventricular (LV) hypertrophy (H),
but reversion to V1 with chronic afterload reduction and LVH regression is
not well defined. We randomized SHR at 3-4 months to oral hydralazine (25
mglkg), enalapril (40 mglkg), or placebo. Age matched Wistar Kyoto rats were
controls. Group average systolic blood pressure (mmHg) at baseline was
207 (Plac), 223 (Hydrl), 225 (Enal), and 156 (Cntrl). Rats were studied after
3 months of treatment. Echocardiographic LVmass (LVM) was from the cu-
bic function: LVM (mg) = 1.04[(EDD + PWT + IVS)3 - EDD3]. corrected for
body weight (LVMI), since echocardiography permits better identification of
differing patterns of hypertrophy. Terminal hemodynamics were volumetric
aortic flow (mean: MAF, mllmin) and Millar aortic pressure (mean: MAP). Sys-
temic arterial resistance (SAR) and LV contractility (+dp/dt) was derived from
digitized waveforms. Following termination, LV was harvested and frozen at
-8000 C, and myosin isoforms were determined bygel electrophoresis, with
expression of V1, V2, V3 isoforms as % total. Analysis of variance was per-
formed and group mean values are given below:
LVMI-LV mass index. *p < 0.05, compared with day 0 (same group) or control
*p <. 05, placebo vs Hydrl. and vs Enal. # p < 0.05 placebo vs Enal
Thus, myosin isoform expression reverted to an adult pattern, in response
to long term afterload reduction. Changes in myosin transcriptional patterns
however, require additional assessment. Eccentric hypertrophy accounted
for persistent LVMI following hydralazine, whereas greater LVMI reduction
occurred with ACE inhibition. This suggests that factors other than afterload
reduction contribute to LVMI regression with ACE inhibition.
Both ECG and echo LVH are markers of increased risk, but there is much
less information on interdrug differences in ECG LVH regression. Therefore,
changes in ECG LVH prevalence were examined after 3 mas titration phase
and a 1 yr maintenance phase of randomized double-blind treatment with
atenolol (AT), captopril (CP). clonidine (CL). diltiazem (DT). hydrochloroth-
iazide (HZ), prazosin (PZ) or placebo (PL) in 570 men with mild-moderate hy-
pertension. The prevalence of Sokolow-Lyon (SL) and Minnesota code (MC)
criteria were evaluated, as well as precordial voltage (Svl + Rv5). Percent
changes from baseline were:
Effect of 6 Antihypertensive Drugs on ECG Left
Ventricular Hypertrophy
Vasilios Papademetriou, Elaine Der, John Gottdiener, Barry Materson,
Domenic Reda, Barry M. Massie, VA Monotherapy of Hypertension Study Group.
VAMC and UCSF, San Francisco, CA; Georgetown University Medical Center.
Washington DC
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Perfusion Balloon versus Stent for Acute or
Threatened Closure: Equal Efficacy but Higher
Mortality and Costs After Stenting
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anism on the incidence and outcome of coronary dissection is unknown.
We analyzed 2293 lesions from the Heart Technology Multi-Center Registry
treated with RA to determine predictive factors for and outcomes following
coronary dissections. The incidence of dissection was 8%. Of the dissected
vessels, 22% showed evidence of persistent dye staining. There were no
differences in age (mean, 63yr) and gender (70% male) between the dissec-
tion and non-dissection groups. The incidence of hypertension, diabetes, hy-
percholesterolemia and smoking was not increased in patients with dissec-
tions. The frequency of prior MI, prior CABG and unstable symptoms was not
greater in patients with dissection. Patients with dissections were more likely
to have calcified lesions (57% vs 49%; p = 0.01), tortuous vessels (36% vs
23%; P < 0.001), AHA/ACC type C lesions (29% vs 18%; p = 0.0001) and
primary (79% vs 67%: p < 0.001) rather than restenotic lesions compared to
patients without dissection. Maximal burr size did not differ between the dis-
section and non-dissection groups. Following dissection, 15% of vessels had
sub-TIMIIII flow. Adjunctive PTCA increased the TIMIIiI flow rate to 94%. The
occurrence of dissection was associated with a greater residual stenosis fol-
lowing RA when compared to vessels without dissection (43% vs 38%) but
that difference was negated following adjunctive PTCA (23% vs 20%). Nev-
ertheless, the procedural success rate «50% residual stenosis without ma-
jor complications) was reduced in the presence of dissection (86% vs 96%;
p < 0.001) primarily because patients with dissection more frequently re-
quired CABG than those without dissection (6.4% vs 1.9%; P < 0.001). The
incidence of in-laboratory closure, out-of-Iaboratory closure, coronary pelio-
ration, Q-wave MI, non-Q MI and death were not increased in patients with
dissection.
Conclusion: Coronary dissection is an uncommon complication of RA that
shares many predictors with PTCA but may have a more benign outcome.
, P < 0.002; t P < 0.05; * P < 0.05; 1 P < 0.005
Thus, PB and Swere equally successful forthe treatment of acute or threat-
ened closure, with no significant difference in 3-month event-free survival.
S reclosure resulted in significantly higher mortality and costs due to longer
hospitalization, more repeat angiography and PTCA.
Ebo D. de Muinck, Peter den HeiJer, Hans-Otto Peels, Ad van Boven, Hans
L. Hillege. University Hospital, Groningen, The Netherlands
Treatment of acute or threatened closure during PTCA with a Stack perfusion
balloon (PB) or Palmaz-Schatz stent (S) was compared regarding: success
(stenosis < 50%, TI.M.1. 3 flow and no in-hospital reclosure or restenosis),
3-rnonth event-free survival, and cost of the intervention based on the total
duration of hospitalization, and the number of repeat interventions in hospi-
tal and during 3-month follow-up. During 3674 PTCA procedures 75 patients
were treated with a PB and 44 received a S for acute or threatened closure.
There were no statistically significant differences regarding: baseline clinical
characteristics, lesion morphology pre-PTCA and lesion morphology before
PB or S. Costs are: 500 US Dollars for 1 day in hospital. 400 for coronary an-
giography, 4790 for PTCA, 9160 for bypass surgery. Five patients died after S,
1 after PB (P < 0.05). In-hospital reclosure occurred 16 times in 12 patients
after S and in 1 patient after PB (P < 0.0002). The PB was successful in 54
(72%) patients and the S in 29 (66%) (P n.s.) There was no difference in 3-
month event-free survival.
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Stenting for Progressive Dissection During PTCA:
Clinical, Angiographic and Intravascular Ultrasound
Criteria to Define a Low-risk Group not ReqUiring
Subsequent Anticoagulation
Helmut Schuhlen, Rudolf Blaslni, Harald Mudra 1, Volker Klauss 1, Adnan Kastrati,
Eva Zitzmann, Petra Neller, Evelyn Regar, Ralph Paloncy, Albert Schomig.
Medizinische Klinik, Technische Universitat Miinchen Germany; 1 Medizinische Klimk
Innenstadt, Ludwig-Maximilians-UniversitBt MtJnchen, Germany
Days in hospital (median:range)
Repeat angiogram
Repeat PTCA (nj
Bypass surgery (n)
Cost (median;range)
Data from our previous experience with stenting suggest a subgroup of pa-
tients with a low risk for subacute occlusion of the stented vessel. Within
a six month study period, stents were implanted for progressive dissection
in 141 patients. These patients were screened for the following risk crite-
Odds Ratio (95% CI)
5tent (OR, Pvalue)
Final MLD
Final MLD
(0.32, P< 005)
Recent( <6 weeks)M I
(2.71, P < 005)
Final MLD
(006, P < 0005)
-291, P ~ 0004 0.44 (026-0.77)
2.25, P ~ 002 3.96 (1.20-13.14)
2.35, P ~ 0.019 5.41 (133-2204)
330. P ~ 0.0010 322 (1.61-6.47)
Wald statistic
PTCA (OR, Pvalue)
Dissection
(362, <0.005)
Diabetes (2.84, P< 005)
Relerence size (0.31, P < 0.05)
(0.47, P < 0.05)
LAD (2.41, P< 005)
None
Serious angiographic complication
Prior PTCA 01 target lesion
Interaction of thrombus &unstable angina
Interaction of thrombus & vein graft
Major clinical complication
Serious angiographic complication
Predictors 01 Outcomes
Independent Predictors
Procedure Failure:
(final stenosis> 50%
andlor death/M I/CABG
andlor bailout S)
Angiographic Restenosis:
(:::50% diameter steno-
sis at follow-up angiogram)
Conclusion: Prior angioplastyof a target lesion (restenosis) is protective for
angiographic complications with new devices. Intralesional thrombus in the
setting of unstable angina or saphenous vein grafts confers an increased risk
of angiographic complications. These angiographic complications, in turn,
are predictive of major complications including nonfatal MI, emergency by-
pass surgery, and death.
Late Complications:
(out-ai-hospital death/
MI/CABG or repeat PTCA,
mean follow-up time =
8.8 ± 3.4 months)
S. Chiu Wong, Ya Chien Chuang, Richard A. Schatz, Donald S. Baim,
Sheldon Goldberg, Michael W. Cleman, Jeffrey A. Brinker, Steven R. Bailey, Martin
B. Leon. Washington Hospital Center. Washington, DC
Although well established biologic, anatomic, and angiographic predictors of
adverse clinical events are known for PTCA, there are a paucity of data af-
ter stent (S) implantation. Therefore we compared independent predictors
for adverse clinical events (procedural failure, restenosis, and late complica-
tions) after S (N = 205) vs PTCA (N = 202) treatment from the randomized
multicenter ~ent Restenosis ~tudy (STRESS) by performing multivariate lo-
gistic analysis.
were performed on 596 lesions in 561 patients including excimer laser angio-
plasty (n = 125), rotablator atherectomy (n = 111), and transluminal extrac-
tion atherectomy (n = 330) followed by adjunctive PTCA in 84% of lesions.
Final procedural success was achieved in 86%. Serious angiographic com-
plications (sidebranch occlusion, distal embolization, no reflow, abrupt clo-
sure, perforation) occurred in 9.4% of procedures after the new device and
persisting in 3.2% after adjunctive PTCA. Major complications (non-Q-wave
infarction, Q-wave infarction, emergency bypass surgery, death) occurred in
9.1 % of patients. Multiple logistic regression was performed on all clinical
and angiographic variables to identify independent predictors of serious an-
giographic and clinical complications:
In S pts, final minimal lumen diameter(MLD) strongly influenced procedure
failure, angiographic restenosis, and late complications. In PTCA pts, post-
PTCA dissection predicted procedural failure; diabetes, reference size, and
LAD predicted restenosis: there were no predictors of late complications.
In conclusion: The multivariate analysis of STRESS pt outcomes indicates
1) predictors for adverse clinical events were different for Sand PTCA, 2) S
neutralized the deleterious impact of biologic and anatomic factors on angio-
graphic restenosis and 3)final MLD after S placement, an operator-controlled
variable, strikingly predicted all adverse clinical outcomes. Therefore, metic-
ulous operator attention to optimize final MLD after S placement with appro-
priate adjunct PTCA may further improve clinical outcomes.
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Predictors for Adverse Clinical Events are Different in
Stents and PTCA: Results from the STent REStenosis
Study
David L. Brown, Frank Giordano, Maurice Buchbinder. University of California, San
Diego Medical Center. San Diego, CA
Rotational atherectomy (RA) employs a novel methodology to debulk coro-
nary lesions. Ratherthan improving lumen dimension by stretching and split-
ting the artery as with balloon angioplasty (PTCA), RA differentially abrades
the less compliant atherosclerotic lesion. The effect of this unique mech-
1720-41 Coronary Dissection Following Rotational
Atherectomy: Clinical Characteristics, Angiographic
Predictors and Acute Outcomes
